UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 9, 2012
Accession Number:
0001193125-12-186435
Submission Type:
POS AM
CIK:
0000822411
Company Name:
ImmunoCellular Therapeutics, Ltd.
File Number:
333-167207